Floatz logo

o6-benzylguanine

Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System

SWOG Cancer Research NetworkSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Malignant Neoplasms of Eye, Brain and Other Parts of Central Nervous System cohort.

Asset / SponsorPhaseRating
CARMUSTINE
SWOG Cancer Research Network
Phase 3B
Rvp-001
Reveal Pharmaceuticals Inc.
Phase 2B
Avapritinib
M.D. Anderson Cancer Center
Phase 2CCC
TZ-3321
Washington University School of Medicine
Phase 2CCC
Bms-907351
National Cancer Institute (NCI)
Phase 2CCC

View all 13 →

Same molecule, other indications

o6-benzylguanine is also rated in:

central nervous system neoplasmDormant
B
Indicative ·
60 / 100
View asset →
gliosarcomaDormant
B
Indicative ·
59 / 100
View asset →
brain neoplasmDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →